
Paxlovid appears to living up to its reputation as the Tamiflu treatment for COVID-19, maintaining its effectiveness even against emerging variants, a new study shows. The antiviral COVID pill reduced the risk of hospitalization by 45% when administered to people infected by the coronavirus, researchers report. The protection was lower than the 90% reduction in… read on > read on >